Speaker

Jing Li

Founder & Chief Executive Officer, VelaVigo

Jing Li, Founder & Chief Executive Officer at VelaVigo, spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Tumor Selectivity Strategies Across Multispecifics, TCEs, & ADCs: What Have we Learnt so Far?”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Oncology & Cancer Research

Past appearances

Oncology & Immunology Innovation Partnering & Licensing Summit
9–10 Sept 2026Boston, United States of America
- PanelTumor Selectivity Strategies Across Multispecifics, TCEs, & ADCs: What Have we Learnt so Far?With John Flygare, David Poon, Ugur Eskiocak, Arne Scheu, Paul Moore

More speakers at Oncology & Immunology Innovation Partnering & Licensing Summit

Carla Bauer
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Akihiro Furukawa
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Adam Gilbert
Science Partner, Flagship Pioneering
Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Jason Kantor
Chief Business Officer, Nurix Therapeutics, Inc.
Nikhil Mutyal
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

See all 53 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jing Li, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].